Refine search

Search Substrates and Products (Substrate)

Substrates and Products (Substrate): show results

Don't show organism specific information (fast!)

Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)

(Not possible to combine with the first option)

Refine your search

Recommended Name:

EC Number:

Commentary Substrates:

Literature (Substrates):

Organism:

Products:

Commentary (Products):

Reversibility:

Search term:

Results 1 - 10 of 11

EC Number	Substrates	Commentary Substrates	Organism	Products	Commentary (Products)	Reversibility
1.4.1.10	glyoxylate + NH3 + NADH	-	Mycolicibacterium smegmatis	glycine + H2O + NAD+	-	r
1.4.1.10	glyoxylate + NH3 + NADH	-	Mycobacterium tuberculosis	glycine + H2O + NAD+	-	r
1.4.1.10	glyoxylate + NH3 + NADH	alternate pathway for formation of glycine in absence of transamination	Mycobacterium tuberculosis	glycine + H2O + NAD+	-	r
1.4.1.10	glyoxylate + NH3 + NADH	-	Mycobacterium tuberculosis H37Ra / ATCC 25177	glycine + H2O + NAD+	-	r
1.4.1.10	glyoxylate + NH3 + NADH	alternate pathway for formation of glycine in absence of transamination	Mycobacterium tuberculosis H37Ra / ATCC 25177	glycine + H2O + NAD+	-	r
1.4.1.10	glyoxylate + NH3 + NADH + H+	-	Mycobacterium tuberculosis	glycine + H2O + NAD+	-	ir
1.4.1.10	glyoxylate + NH3 + NADH + H+	-	Mycobacterium tuberculosis H37Rv	glycine + H2O + NAD+	-	ir
1.4.1.10	more	not: acetic acid, oxalic acid	Mycobacterium tuberculosis	?	-	?
1.4.1.10	more	the putative glycine dehydrogenase of Mycobacterium tuberculosis catalyzes the reductive amination of glyoxylate to glycine but not the reverse reaction. It exhbits both pyruvate and glyoxylate aminating activitiesand also shows alanine dehydrogenase activity, EC 1.4.1.1, to a greater extent than glyoxylate aminating activity	Mycobacterium tuberculosis	?	-	?
1.4.1.10	more	not: acetic acid, oxalic acid	Mycobacterium tuberculosis H37Ra / ATCC 25177	?	-	?

Results 1 - 10 of 11

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)